Omegapres versus solifenacin plus mirabegron for children with primary mono‑symptomatic nocturnal enuresis
Official title: A Randomized Controlled Trial Comparing Mirabegron and Solifenacin Combination Therapy Versus Desmopressin Monotherapy in Treatment of Children With Primary Mono-Symptomatic Nocturnal Enuresis
Run by Mansoura University · NCT07199894 · Data updated 2026-11-12
This tests whether a daily combination of solifenacin and mirabegron reduces nightly bedwetting more than Omegapres in children with primary mono‑symptomatic nocturnal enuresis.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 6 Years to 18 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Mansoura University Academic / other |
| Locations | 1 site (Al Mansurah) |
| Status | Recruiting |
| Started | December 1, 2024 |
| Main results expected | December 1, 2025 |
| Study ends | February 1, 2026 |
| Registry record updated | September 30, 2025 |
| Trial ID | NCT07199894 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 5 years or older with primary mono‑symptomatic nocturnal enuresis and no other lower urinary tract symptoms are the intended participants.
✕Probably not a fit
Children with bowel dysfunction, psychiatric illness, respiratory sleep disorders, congenital urinary tract anomalies, or non‑mono‑symptomatic enuresis are unlikely to benefit from this regimen.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children with primary mono‑symptomatic nocturnal enuresis will receive either a daily combination of solifenacin and mirabegron or Omegapres for three months and will be followed monthly. Caregivers will keep a diary of wet nights and symptoms while clinic visits include checks and safety tests. The trial's main outcomes are change in number of wet nights and the safety/tolerability of the drug combination. Participants with bowel dysfunction, psychiatric illness, or respiratory sleep disorders are excluded.
Why it matters
Potential benefit: If successful, the combination could reduce the number of wet nights and provide an alternative for children who do not respond to desmopressin alone.
How similar studies have gone: Smaller studies and off‑label use of anticholinergics and mirabegron have shown benefit for detrusor overactivity and some enuresis cases, but large phase‑3 data combining these two drugs versus desmopressin are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Primary mono-symptomatic nocturnal enuresis - Exclusion Criteria: Bowel dysfunction Psychatric illness Respiratory sleep disorders \-
Where it's running
-
Urology and Nephrology center - Mansoura University
Al Mansurah, Egypt Recruiting
Study contacts
- Study coordinator: Abdelhamid El Sayed Shahin, MBBCH
- Email: hameedshahin95@gmail.com
- Phone: +201005876463
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pelvic floor muscle rehabilitation with desmopressin for children with bedwetting
This study is testing if combining pelvic floor muscle exercises with a medication can help children aged 7 to 13 who wet the bed at night have fewer accidents and stay dry longer.
-
Individualized pelvic floor rehab added to standard urotherapy and alarm therapy for kids with bedwetting
This trial tests whether adding personalized pelvic floor muscle training to standard alarm therapy helps reduce dry nights in children aged 5–18 with primary monosymptomatic nocturnal enuresis.
-
Bedtime device restriction plus desmopressin for bedwetting in kids
This trial tests whether limiting screen time at night helps desmopressin work better for children with primary monosymptomatic nocturnal enuresis.
-
Relaxation-based bladder training device for children with daytime wetting, frequent urination, or bedwetting
This trial will test whether a new relaxation-based device helps children with daytime urinary incontinence, urinary frequency, or primary nocturnal enuresis improve bladder control.
-
Using electrical stimulation to treat bedwetting in children
This study is testing if a new electrical stimulation treatment can help children aged 5-17 who struggle with bedwetting after other methods haven't worked.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.